Pricing
Not listed
Official monthly price not confirmed
- API
- Not confirmed
Biotech · Vendor site 2026-10-04
Promakhos Therapeutics is a Boston-based biotech company developing medicines for autoinflammatory diseases by restoring immune balance instead of broadly suppressing immunity. The team uses insights from patient samples to target root causes of chronic inflammation.
Patients, clinicians, and partners following novel autoinflammatory therapies—not a software buyer audience.
Corporate site describes R&D pipeline and team bios without commercial software or subscription offerings.
Promakhos describes a Boston startup founded in 2021 to create therapies that help the body control inflammation and heal.
What it can do
Unknown is different from unavailable. Each fact carries its own evidence.
| Capability | Value | Evidence | Checked |
|---|---|---|---|
| Therapeutic focus | Site states the company develops transformative medicines for inflammatory diseases such as Crohn’s and psoriasis. | Facts sourced | 2026-10-04 |
| Immune restoration | Marketing contrasts restoring immune function with traditional immunosuppressive therapies. | Facts sourced | 2026-10-04 |
Understand the total cost
Pricing
Not listed
Official monthly price not confirmed
Picked monitors how selected AI engines answer buyer questions about a brand. It compares mentions and source citations and offers drafted content and crawler-log analysis for a team to review.
Explore toolStartories combines public buying-signal discovery, company and decision-maker matching, business-email verification and personalized outbound sequences. It advertises human targeting/message review, reply classification and stop-on-reply follow-ups.
Explore toolZendesk AI powers the company's Resolution Platform with AI agents, Copilot, intelligent automation, and knowledge tools that learn from service interactions. It is sold as part of Zendesk customer service plans rather than a standalone chatbot app.
Explore toolThe practical questions
Promakhos Therapeutics is a Boston-based biotech company developing medicines for autoinflammatory diseases by restoring immune balance instead of broadly suppressing immunity. The team uses insights from patient samples to target root causes of chronic inflammation.
Not confirmed. This record does not confirm an ongoing free plan.
A listed monthly price has not been confirmed. See the plan cards for entitlements, billing commitments and seat minimums.
Not confirmed. API access and subscription access may have different terms; consult the linked sources.
Corporate site describes R&D pipeline and team bios without commercial software or subscription offerings.
No retained pricing changes yet. A current price alone does not establish a historical trend.
Reviewed vendor source
Read original source ↗Facts apply to the named version and check date. Send a sourced correction if something changed.